Your healthcare provider will need to assess whether you meet the criteria for GLP-1 receptor agonist therapy, which typically includes having type 2 diabetes with inadequate control on metformin alone (HbA1c above target) according to NICE guideline NG28
For more on the research landscape, see our overview of GHK-Cu: The Anti-Aging Copper Peptide
Interestingly, much of the research has been based on doses far exceeding the recommended daily intake, both in individuals with pathological conditions and in healthy subjects
ANCA binding to their target cell surface antigens activate neutrophils and monocytes that subsequently contribute to vascular inflammation and injury
Along with muscular weakness, there was progressing intracranial (sinus sagittal superior), portal and caval hypertension, and aortal hypotension, progressing thrombosis, in arteries and veins, both peripherally and centrally, severe ECG disturbances, and severe lesions in the brain, heart, lung, liver, kidney and gastrointestinal tract [80]
